The thesis

Verisk sells risk-assessment and catastrophe-modeling analytics to insurers, a high-value niche that sustains a 70.2% gross margin and a 27.7% net margin. Revenue grew 5.3% year over year, slow for a business trading at 31 times earnings. Analysts consensus-rate the stock a buy, yet our conviction signal sits at 35 out of 100, a watchlist score that withholds endorsement. The tension is plain: the market prices Verisk as a compounder while the growth line reads like a mature utility, and the artificial-intelligence capital-spending cycle that lifts its software peers is currently inactive as a driver for this name.

Why now

Consensus optimism and our cautious score are as far apart as they get, and that gap must close either through faster growth or a rerating. With chipmakers pushing up packaging prices and AI infrastructure costs climbing, attention turns to which software names actually convert that spending into revenue, and Verisk's 5.3% growth says it has not yet.

What to watch

Watch whether quarterly revenue growth accelerates from 5.3% toward the high single digits, the threshold that justifies a 31-times multiple. Watch management's commentary for AI-driven product demand and any change in our conviction score above the 35 watchlist level over the next one to three quarters.

Key risks

At 31 times earnings, any stay near 5% growth invites multiple compression toward utility-like valuations. Verisk sits outside the active AI capital-spending flow, so the theme that re-rates software could skip it entirely. Rising chip and packaging costs also pressure the cloud infrastructure budgets its platform theme depends on.

Theme exposure